Compare Stocks

3 / 10
Try these comparisons:

Stock Comparison

AHG vs JFIN vs QFIN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
AHG
Akso Health Group

Financial - Credit Services

Financial ServicesNASDAQ • CN
Market Cap$584M
5Y Perf.-39.5%
JFIN
Jiayin Group Inc.

Internet Content & Information

Communication ServicesNASDAQ • CN
Market Cap$534M
5Y Perf.+138.6%
QFIN
Qfin Holdings, Inc.

Financial - Credit Services

Financial ServicesNASDAQ • CN
Market Cap$3.75B
5Y Perf.+31.4%

AHG vs JFIN vs QFIN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
AHG logoAHG
JFIN logoJFIN
QFIN logoQFIN
IndustryFinancial - Credit ServicesInternet Content & InformationFinancial - Credit Services
Market Cap$584M$534M$3.75B
Revenue (TTM)$15M$6.54B$17.17B
Net Income (TTM)$-135M$1.71B$6.89B
Gross Margin-1.9%80.9%61.8%
Operating Margin-11.3%32.1%43.9%
Forward P/E0.5x0.5x0.5x
Total Debt$82K$52M$1.65B
Cash & Equiv.$176M$541M$4.45B

AHG vs JFIN vs QFINLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

AHG
JFIN
QFIN
StockMay 20May 26Return
Akso Health Group (AHG)10060.5-39.5%
Jiayin Group Inc. (JFIN)100238.6+138.6%
Qfin Holdings, Inc. (QFIN)100131.4+31.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: AHG vs JFIN vs QFIN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AHG leads in 3 of 7 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. Jiayin Group Inc. is the stronger pick specifically for dividend income and shareholder returns and operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
AHG
Akso Health Group
The Banking Pick

AHG has the current edge in this matchup, primarily because of its strength in growth exposure and sleep-well-at-night.

  • Rev growth 5.1%, EPS growth -23.1%
  • Lower volatility, beta 0.14, Low D/E 0.0%, current ratio 14.20x
  • Beta 0.14, current ratio 14.20x
Best for: growth exposure and sleep-well-at-night
JFIN
Jiayin Group Inc.
The Income Pick

JFIN is the clearest fit if your priority is income & stability.

  • Dividend streak 2 yrs, beta 1.19, yield 16.9%
  • 16.9% yield, 2-year raise streak, vs QFIN's 9.3%, (1 stock pays no dividend)
  • 21.6% ROA vs AHG's -62.8%, ROIC 39.9% vs -73.9%
Best for: income & stability
QFIN
Qfin Holdings, Inc.
The Banking Pick

QFIN is the clearest fit if your priority is long-term compounding and valuation efficiency.

  • 16.1% 10Y total return vs JFIN's -56.7%
  • PEG 0.02 vs JFIN's 0.03
  • Lower P/E (0.5x vs 0.5x), PEG 0.02 vs 0.03
Best for: long-term compounding and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthAHG logoAHG5.1% NII/revenue growth vs QFIN's 5.4%
ValueQFIN logoQFINLower P/E (0.5x vs 0.5x), PEG 0.02 vs 0.03
Quality / MarginsQFIN logoQFIN36.5% margin vs AHG's -9.1%
Stability / SafetyAHG logoAHGBeta 0.14 vs QFIN's 1.20, lower leverage
DividendsJFIN logoJFIN16.9% yield, 2-year raise streak, vs QFIN's 9.3%, (1 stock pays no dividend)
Momentum (1Y)AHG logoAHG+48.6% vs QFIN's -63.6%
Efficiency (ROA)JFIN logoJFIN21.6% ROA vs AHG's -62.8%, ROIC 39.9% vs -73.9%

AHG vs JFIN vs QFIN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AHGAkso Health Group
FY 2022
Interest income
100.0%$215,393
JFINJiayin Group Inc.
FY 2022
Loan Facilitation Services
88.1%$2.9B
Other Revenues
11.9%$390M
QFINQfin Holdings, Inc.
FY 2024
Credit driven services
43.9%$11.7B
Financial Service
24.9%$6.6B
Platform services
20.4%$5.4B
Revenue From Loan Facilitation Services Under Fees Capital Light
4.7%$1.2B
Revenue from Loan Facilitation Services Under Fees Capital Light
3.3%$870M
Revenue from post-facilitation services
1.4%$378M
Other services fees.
1.4%$371M

AHG vs JFIN vs QFIN — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAHGLAGGINGJFIN

Income & Cash Flow (Last 12 Months)

QFIN leads this category, winning 3 of 5 comparable metrics.

QFIN is the larger business by revenue, generating $17.2B annually — 1161.6x AHG's $15M. QFIN is the more profitable business, keeping 36.5% of every revenue dollar as net income compared to AHG's -9.1%.

MetricAHG logoAHGAkso Health GroupJFIN logoJFINJiayin Group Inc.QFIN logoQFINQfin Holdings, In…
RevenueTrailing 12 months$15M$6.5B$17.2B
EBITDAEarnings before interest/tax-$164M$2.1B$8.0B
Net IncomeAfter-tax profit-$135M$1.7B$6.9B
Free Cash FlowCash after capex$1M$0$10.8B
Gross MarginGross profit ÷ Revenue-1.9%+80.9%+61.8%
Operating MarginEBIT ÷ Revenue-11.3%+32.1%+43.9%
Net MarginNet income ÷ Revenue-9.1%+26.2%+36.5%
FCF MarginFCF ÷ Revenue+6.9%+11.8%+53.5%
Rev. Growth (YoY)Latest quarter vs prior year+1.8%
EPS Growth (YoY)Latest quarter vs prior year-53.8%+44.9%-9.7%
QFIN leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

QFIN leads this category, winning 4 of 7 comparable metrics.

At 1.7x trailing earnings, JFIN trades at a 21% valuation discount to QFIN's 2.1x P/E. Adjusting for growth (PEG ratio), QFIN offers better value at 0.11x vs JFIN's 0.12x — a lower PEG means you pay less per unit of expected earnings growth.

MetricAHG logoAHGAkso Health GroupJFIN logoJFINJiayin Group Inc.QFIN logoQFINQfin Holdings, In…
Market CapShares × price$584M$534M$3.8B
Enterprise ValueMkt cap + debt − cash$408M$462M$3.3B
Trailing P/EPrice ÷ TTM EPS-4.27x1.69x2.15x
Forward P/EPrice ÷ next-FY EPS est.0.51x0.49x0.47x
PEG RatioP/E ÷ EPS growth rate0.12x0.11x
EV / EBITDAEnterprise value multiple2.48x2.99x
Price / SalesMarket cap ÷ Revenue39.55x0.63x1.49x
Price / BookPrice ÷ Book value/share2.93x0.57x0.56x
Price / FCFMarket cap ÷ FCF571.47x5.29x2.78x
QFIN leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

Evenly matched — JFIN and QFIN each lead in 3 of 8 comparable metrics.

JFIN delivers a 39.7% return on equity — every $100 of shareholder capital generates $40 in annual profit, vs $-68 for AHG. AHG carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to QFIN's 0.07x. On the Piotroski fundamental quality scale (0–9), QFIN scores 7/9 vs AHG's 4/9, reflecting strong financial health.

MetricAHG logoAHGAkso Health GroupJFIN logoJFINJiayin Group Inc.QFIN logoQFINQfin Holdings, In…
ROE (TTM)Return on equity-67.8%+39.7%+28.8%
ROA (TTM)Return on assets-62.8%+21.6%+12.2%
ROICReturn on invested capital-73.9%+39.9%+23.1%
ROCEReturn on capital employed-98.0%+32.2%+35.6%
Piotroski ScoreFundamental quality 0–9467
Debt / EquityFinancial leverage0.00x0.02x0.07x
Net DebtTotal debt minus cash-$176M-$489M-$2.8B
Cash & Equiv.Liquid assets$176M$541M$4.5B
Total DebtShort + long-term debt$81,737$52M$1.7B
Interest CoverageEBIT ÷ Interest expense
Evenly matched — JFIN and QFIN each lead in 3 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

AHG leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in AHG five years ago would be worth $14,236 today (with dividends reinvested), compared to $8,090 for QFIN. Over the past 12 months, AHG leads with a +48.6% total return vs QFIN's -63.6%. The 3-year compound annual growth rate (CAGR) favors AHG at 87.1% vs QFIN's 0.2% — a key indicator of consistent wealth creation.

MetricAHG logoAHGAkso Health GroupJFIN logoJFINJiayin Group Inc.QFIN logoQFINQfin Holdings, In…
YTD ReturnYear-to-date+28.1%-17.9%-22.5%
1-Year ReturnPast 12 months+48.6%-54.2%-63.6%
3-Year ReturnCumulative with dividends+555.0%+36.4%+0.6%
5-Year ReturnCumulative with dividends+42.4%+21.2%-19.1%
10-Year ReturnCumulative with dividends-97.1%-56.7%+16.1%
CAGR (3Y)Annualised 3-year return+87.1%+10.9%+0.2%
AHG leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

AHG leads this category, winning 2 of 2 comparable metrics.

AHG is the less volatile stock with a 0.14 beta — it tends to amplify market swings less than QFIN's 1.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AHG currently trades 82.0% from its 52-week high vs JFIN's 25.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricAHG logoAHGAkso Health GroupJFIN logoJFINJiayin Group Inc.QFIN logoQFINQfin Holdings, In…
Beta (5Y)Sensitivity to S&P 5000.14x1.19x1.20x
52-Week HighHighest price in past year$2.50$19.23$47.00
52-Week LowLowest price in past year$1.07$3.71$12.30
% of 52W HighCurrent price vs 52-week peak+82.0%+25.7%+28.1%
RSI (14)Momentum oscillator 0–10046.254.053.7
Avg Volume (50D)Average daily shares traded147K63K1.4M
AHG leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

JFIN leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: JFIN as "Buy", QFIN as "Buy". For income investors, JFIN offers the higher dividend yield at 16.87% vs QFIN's 9.26%.

MetricAHG logoAHGAkso Health GroupJFIN logoJFINJiayin Group Inc.QFIN logoQFINQfin Holdings, In…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$28.15
# AnalystsCovering analysts14
Dividend YieldAnnual dividend ÷ price+16.9%+9.3%
Dividend StreakConsecutive years of raises121
Dividend / ShareAnnual DPS$5.67$8.32
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.5%+11.6%
JFIN leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

QFIN leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). AHG leads in 2 (Total Returns, Risk & Volatility). 1 tied.

Best OverallAkso Health Group (AHG)Leads 2 of 6 categories
Loading custom metrics...

AHG vs JFIN vs QFIN: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is AHG or JFIN or QFIN a better buy right now?

For growth investors, Akso Health Group (AHG) is the stronger pick with 512.

1% revenue growth year-over-year, versus 5. 4% for Qfin Holdings, Inc. (QFIN). Jiayin Group Inc. (JFIN) offers the better valuation at 1. 7x trailing P/E (0. 5x forward), making it the more compelling value choice. Analysts rate Jiayin Group Inc. (JFIN) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — AHG or JFIN or QFIN?

On trailing P/E, Jiayin Group Inc.

(JFIN) is the cheapest at 1. 7x versus Qfin Holdings, Inc. at 2. 1x. On forward P/E, Qfin Holdings, Inc. is actually cheaper at 0. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Qfin Holdings, Inc. wins at 0. 02x versus Jiayin Group Inc. 's 0. 03x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — AHG or JFIN or QFIN?

Over the past 5 years, Akso Health Group (AHG) delivered a total return of +42.

4%, compared to -19. 1% for Qfin Holdings, Inc. (QFIN). Over 10 years, the gap is even starker: QFIN returned +16. 1% versus AHG's -97. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — AHG or JFIN or QFIN?

By beta (market sensitivity over 5 years), Akso Health Group (AHG) is the lower-risk stock at 0.

14β versus Qfin Holdings, Inc. 's 1. 20β — meaning QFIN is approximately 740% more volatile than AHG relative to the S&P 500. On balance sheet safety, Akso Health Group (AHG) carries a lower debt/equity ratio of 0% versus 7% for Qfin Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — AHG or JFIN or QFIN?

By revenue growth (latest reported year), Akso Health Group (AHG) is pulling ahead at 512.

1% versus 5. 4% for Qfin Holdings, Inc. (QFIN). On earnings-per-share growth, the picture is similar: Qfin Holdings, Inc. grew EPS 60. 7% year-over-year, compared to -23. 1% for Akso Health Group. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — AHG or JFIN or QFIN?

Qfin Holdings, Inc.

(QFIN) is the more profitable company, earning 36. 5% net margin versus -913. 4% for Akso Health Group — meaning it keeps 36. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: QFIN leads at 43. 9% versus -1125. 4% for AHG. At the gross margin level — before operating expenses — JFIN leads at 64. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is AHG or JFIN or QFIN more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Qfin Holdings, Inc. (QFIN) is the more undervalued stock at a PEG of 0. 02x versus Jiayin Group Inc. 's 0. 03x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Qfin Holdings, Inc. (QFIN) trades at 0. 5x forward P/E versus 0. 5x for Akso Health Group — 0. 0x cheaper on a one-year earnings basis.

08

Which pays a better dividend — AHG or JFIN or QFIN?

In this comparison, JFIN (16.

9% yield), QFIN (9. 3% yield) pay a dividend. AHG does not pay a meaningful dividend and should not be held primarily for income.

09

Is AHG or JFIN or QFIN better for a retirement portfolio?

For long-horizon retirement investors, Akso Health Group (AHG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

14)). Both have compounded well over 10 years (AHG: -97. 1%, JFIN: -56. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between AHG and JFIN and QFIN?

These companies operate in different sectors (AHG (Financial Services) and JFIN (Communication Services) and QFIN (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AHG is a small-cap high-growth stock; JFIN is a small-cap deep-value stock; QFIN is a small-cap deep-value stock. JFIN, QFIN pay a dividend while AHG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

AHG

High-Growth Disruptor

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 256%
Run This Screen
Stocks Like

JFIN

Dividend Mega-Cap Quality

  • Sector: Communication Services
  • Market Cap > $100B
  • Net Margin > 15%
  • Dividend Yield > 6.7%
Run This Screen
Stocks Like

QFIN

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 21%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform AHG and JFIN and QFIN on the metrics below

Revenue Growth>
%
(AHG: 512.1% · JFIN: 1.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.